Please try another search
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. It also provides over the counter products, including SprinJene, an oral care product; and RAF FIVE, a dermatology product, as well as Zyraydi, an enhanced distillate capture and dissolution matrix technology. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is headquartered in Perth, Australia.
Name | Age | Since | Title |
---|---|---|---|
Dustin Sulak | - | 2018 | Scientific & Medical Advisory Board |
Oludare Odumosu | - | 2019 | MD, Global CEO & Director |
Cristina Sanchez | - | - | Member of Medical Advisory Board |
Joe Goldstrich | - | 2016 | Member of Medical Advisory Board |
Osagie O. Imasogie | 60 | 2019 | Founder & Chairman |
David Casarett | - | 2018 | Scientific & Medical Advisory Board |
Manuel Guzman | - | - | Member of Medical Advisory Board |
Mara Gordon | 62 | 2015 | Member of Medical Advisory Board |
Noah Federman | - | 2016 | Member of Medical Advisory Board |
Greg Blake | - | 2023 | Executive Director |
Timothy Ryan Slate | - | 2016 | Company Secretary & Non-Executive Director |
Donna Gentile O’Donnell | - | 2023 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review